|
1
|
Cari L, De Rosa F, Nocentini G and
Riccardi C: Context-dependent effect of glucocorticoids on the
proliferation, differentiation, and apoptosis of regulatory T
cells: A review of the empirical evidence and clinical
applications. Int J Mol Sci. 20(pii): E11422019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mylka V, Deckers J, Ratman D, De Cauwer L,
Thommis J, De Rycke R, Impens F, Libert C, Tavernier J, Vanden
Berghe W, et al: The autophagy receptor SQSTM1/p62 mediates
anti-inflammatory actions of the selective NR3C1/glucocorticoid
receptor modulator compound A (CpdA) in macrophages. Autophagy.
14:2049–2064. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Patil RH, Naveen Kumar M, Kiran Kumar KM,
Nagesh R, Kavya K, Babu RL, Ramesh GT and Chidananda Sharma S:
Dexamethasone inhibits inflammatory response via down regulation of
AP-1 transcription factor in human lung epithelial cells. Gene.
645:85–94. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Achuthan A, Aslam ASM, Nguyen Q, Lam PY,
Fleetwood AJ, Frye AT, Louis C, Lee MC, Smith JE, Cook AD, et al:
Glucocorticoids promote apoptosis of proinflammatory monocytes by
inhibiting ERK activity. Cell Death Dis. 9:2672018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li B, Wang Y, Yin L, Huang G, Xu Y, Su J,
Ma L and Lu J: Glucocorticoids promote the development of
azoxymethane and dextran sulfate sodium-induced colorectal
carcinoma in mice. BMC Cancer. 19:942019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang C, Nanni L, Novakovic B,
Megchelenbrink W, Kuznetsova T, Stunnenberg HG, Ceri S and Logie C:
Extensive epigenomic integration of the glucocorticoid response in
primary human monocytes and in vitro derived macrophages. Sci Rep.
9:27722019. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bagati A, Moparthy S, Fink EE,
Bianchi-Smiraglia A, Yun DH, Kolesnikova M, Udartseva OO, Wolff DW,
Roll MV, Lipchick BC, et al: KLF9-dependent ROS regulate melanoma
progression in stage-specific manner. Oncogene. 38:3585–3597. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhong Z, Zhou F, Wang D, Wu M, Zhou W, Zou
Y, Li J, Wu L and Yin X: Expression of KLF9 in pancreatic cancer
and its effects on the invasion, migration, apoptosis, cell cycle
distribution, and proliferation of pancreatic cancer cell lines.
Oncol Rep. 40:3852–3860. 2018.PubMed/NCBI
|
|
9
|
Fink EE, Moparthy S, Bagati A,
Bianchi-Smiraglia A, Lipchick BC, Wolff DW, Roll MV, Wang J, Liu S,
Bakin AV, et al: XBP1-KLF9 axis acts as a molecular rheostat to
control the transition from adaptive to cytotoxic unfolded protein
response. Cell Rep. 25:212–223 e4. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Glinghammar B, Skogsberg J, Hamsten A and
Ehrenborg E: PPARdelta activation induces COX-2 gene expression and
cell proliferation in human hepatocellular carcinoma cells. Biochem
Biophys Res Commun. 308:361–368. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Barnard ME, Hecht JL, Rice MS, Gupta M,
Harris HR, Eliassen AH, Rosner BA, Terry KL and Tworoger SS:
Anti-inflammatory drug use and ovarian cancer risk by COX1/COX2
expression and infiltration of tumor-associated macrophages. Cancer
Epidemiol Biomarkers Prev. 27:1509–1517. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lanocha-Arendarczyk N, Baranowska-Bosiacka
I, Kot K, Gutowska I, Kolasa-Wołosiuk A, Chlubek D and
Kosik-Bogacka D: Expression and activity of COX-1 and COX-2 in
Acanthamoeba sp.-Infected lungs according to the host
immunological status. Int J Mol Sci. 19(pii): E1212018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kern MA, Haugg AM, Koch AF, Schilling T,
Breuhahn K, Walczak H, Fleischer B, Trautwein C, Michalski C,
Schulze-Bergkamen H, et al: Cyclooxygenase-2 inhibition induces
apoptosis signaling via death receptors and mitochondria in
hepatocellular carcinoma. Cancer Res. 66:7059–7066. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chen EP, Markosyan N, Connolly E, Lawson
JA, Li X, Grant GR, Grosser T, FitzGerald GA and Smyth EM: Myeloid
Cell COX-2 deletion reduces mammary tumor growth through enhanced
cytotoxic T-lymphocyte function. Carcinogenesis. 35:1788–1797.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chen EP and Smyth EM: COX-2 and
PGE2-dependent immunomodulation in breast cancer. Prostaglandins
Other Lipid Mediat. 96:14–20. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Carey LC, Valego NK, Chen K and Rose JC:
Thyroid hormone regulates renocortical COX-2 and PGE2 expression in
the late gestation fetal sheep. Reprod Sci. 15:598–603. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang Y, Zhou Y, Chen S, Hu Y, Zhu Z and
Wang Y, Du N, Song T, Yang Y, Guo A and Wang Y: Macrophage
migration inhibitory factor facilitates prostaglandin E2 production
of astrocytes to tune inflammatory milieu following spinal cord
injury. J Neuroinflammation. 16:852019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hwang JH, Ma JN, Park JH, Jung HW and Park
YK: Anti-inflammatory and antioxidant effects of MOK, a polyherbal
extract, on lipopolysaccharidestimulated RAW 264.7 macrophages. Int
J Mol Med. 43:26–36. 2019.PubMed/NCBI
|
|
19
|
Yang D, Lv Z, Zhang H, Liu B, Jiang H, Tan
X, Lu J, Baiyun R and Zhang Z: Activation of the Nrf2 signaling
pathway involving KLF9 plays a critical role in allicin resisting
against arsenic trioxide-induced hepatotoxicity in rats. Biol Trace
Elem Res. 176:192–200. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bagheri-Yarmand R, Sinha KM, Li L, Lu Y,
Cote GJ, Sherman SI and Gagel RF: Combinations of tyrosine kinase
inhibitor and ERAD inhibitor promote oxidative stress-induced
apoptosis through ATF4 and KLF9 in medullary thyroid cancer. Mol
Cancer Res. 17:751–760. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yang Y, Wei H, Song T, Cai A, Zhou Y and
Peng J, Jiang S and Peng J: E4BP4 mediates glucocorticoid-regulated
adipogenesis through COX2. Mol Cell Endocrinol. 450:43–53. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Majumder M, Xin X, Liu L, Tutunea-Fatan E,
Rodriguez-Torres M, Vincent K, Postovit LM, Hess D and Lala PK:
COX-2 induces breast cancer stem cells via EP4/PI3K/AKT/NOTCH/WNT
axis. Stem Cells. 34:2290–2305. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lin HY, Davis PJ, Tang HY, Mousa SA,
Luidens MK, Hercbergs AH and Davis FB: The pro-apoptotic action of
stilbene-induced COX-2 in cancer cells: Convergence with the
anti-apoptotic effect of thyroid hormone. Cell Cycle. 8:1877–1882.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li Y, Zou L, Li T, Lai D, Wu Y and Qin S:
Mogroside V inhibits LPS-induced COX-2 expression/ROS production
and overexpression of HO-1 by blocking phosphorylation of AKT1 in
RAW264.7 cells. Acta Biochim Biophys Sin (Shanghai). 51:365–374.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chang J, Xue M, Yang S, Yao B, Zhang B,
Chen X, Pozzi A and Zhang MZ: Inhibition of 11β-Hydroxysteroid
dehydrogenase Type II suppresses lung carcinogenesis by blocking
tumor COX-2 expression as well as the ERK and mTOR signaling
pathways. PLoS One. 10:e01270302015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Park J, Ha SH, Abekura F, Lim H, Magae J,
Ha KT, Chung TW, Chang YC, Lee YC, Chung E, et al:
4-O-Carboxymethylascochlorin inhibits expression levels of on
inflammation-related cytokines and matrix metalloproteinase-9
through NF-κB/MAPK/TLR4 signaling pathway in LPS-activated RAW264.7
cells. Front Pharmacol. 10:3042019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Greene ER, Huang S, Serhan CN and
Panigrahy D: Regulation of inflammation in cancer by eicosanoids.
Prostaglandins Other Lipid Mediat. 96:27–36. 2011. View Article : Google Scholar : PubMed/NCBI
|
